SEARCH

SEARCH BY CITATION

References

  • 1
    AABB Extracorporeal Therapy Committee (1992) Guidelines for Therapeutic Hemapheresis: 1992–3. American Association of Blood Banks, Bethesda, MD.
  • 2
    Ahn, Y.S., Harrington, W.J., Seelman, R.C., Eytel, C.S. (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. New England Journal of Medicine, 291, 376 380.
  • 3
    Ahn, Y.S., Jy, W., Kolodny, L., Horstman, L.L., Mao, W.W., Valant, P.A., Duncan, R.C. (1996) Activated platelet aggregates in thrombotic thrombocytopenic purpura: decrease with plasma infusions and normalization in remission. British Journal of Haematology, 95, 408 415.
  • 4
    Amorosi, E.L. & Ultmann, J.E. (1966) Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore), 45, 139 159.
  • 5
    Ansell, J., Beaser, R.S., Pechet, L. (1978) Thrombotic thrombocytopenic purpura fails to respond to fresh frozen plasma infusion. Annals of Internal Medicine, 89, 647 648.
  • 6
    Arcan, J.C., Blanchard, J., Boissel, J.P., Destors, J.M., Panak, E. (1988) Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complication. Angiology, 39, 802 811.
  • 7
    Asada, Y., Sumiyoshi, A., Hayashi, T., Suzumiya, J., Kaketani, K. (1985) Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to Factor VIII related antigen. Thrombosis Research, 38, 469 479.
  • 8
    Bandarenko, N. & Brecher, M.E. (1998) United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. Journal of Clinical Apheresis, 13, 133 141.
  • 9
    Bell, W.R., Braine, H.G., Ness, P.M., Kickler, T.S. (1991) Improved survival in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Clinical experience in 108 patients. New England Journal of Medicine, 325, 398 403.
  • 10
    Bennett, C.L., Weinberg, P.D., Rozenberg-Ben-Dror, K., Yarnold, P.R., Kwaan, H.C., Green, D. (1998) Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Annals of Internal Medicine, 128, 541 544.
  • 11
    Bobbio-Pallavicini, E., Porta, C., Centurioni, R., Gugliotta, L., Vianelli, N., Tacconi, F., Billio, A., Ascari, E. (1994) Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP. European Journal of Haematology, 52, 222 226.
  • 12
    Bobbio-Pallavicini, E., Gugliotta, L., Centurioni, R., Porta, C., Vianelli, N., Billio, A., Tacconi, F., Ascari, E. (1997) Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica, 82, 429 435.
  • 13
    Brailey, L.L., Brecher, M.E., Bandarenko, N. (1999) Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management. Therapeutic Apheresis, 3, 20 24.
  • 14
    Burns, E.R. & Zucker-Franklin, D. (1982) Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood, 60, 1030 1037.
  • 15
    Byrnes, J.J. & Khurana, M. (1977) Treatment of thrombotic thrombocytopenic purpura with plasma. New England Journal of Medicine, 297, 1386 1389.
  • 16
    Byrnes, J.J., Moake, J.L., Klug, P., Periman, P. (1990) Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. American Journal of Hematology, 34, 169 174.
  • 17
    Caggiano, V., Fernando, L.P., Schneider, J.M., Haesslein, H.C., Watson-Williams, E.J. (1983) Thrombotic thrombocytopenic purpura: report of fourteen cases – occurrence during pregnancy and response to plasma exchange. Journal of Clinical Apheresis, 1, 71 85.
  • 18
    Chart, H., Smith, H.R., Scotland, S.M., Rowe, B., Milford, D.V., Taylor, C.M. (1991) Serological identification of Escherichia coli O157: H7 infection in haemolytic uraemic syndrome. Lancet, 337 (8734), 138 140.
  • 19
    Chow, T.W., Turner, N.A., Chintagumpala, M., McPherson, P.D., Nolasco, L.H., Rice, L., Hellums, J.D., Moake, J.L. (1998) Increased Von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. American Journal of Hematology, 57, 293 302.
  • 20
    Cohen, J.A., Brecher, M.E., Bandarenko, N. (1998) Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis, 13, 16 19.
  • 21
    Crowther, M.A., Heddle, N., Hayward, C.P., Warkentin, T., Kelton, J.G. (1996) Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Annals of Internal Medicine, 125, 294 296.
  • 22
    Dang, C.T., Magid, M.S., Weksler, B., Chadburn, A., Laurence, J. (1999) Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood, 93, 1264 1270.
  • 23
    Dent, J.A., Berkowitz, S.D., Ware, J., Kasper, C.K., Ruggeri, Z.M. (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proceedings of the National Academy of Sciences of the United States of America, 87, 6306 6310.
  • 24
    Ezra, Y., Rose, M., Eldor, A. (1996) Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. American Journal of Hematology, 51, 1 6.
  • 25
    Fraser, J.L., Millenson, M., Malynn, E.R., Uhl, L., Kruskall, M.S. (1996) Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpura. Obstetrics and Gynecology, 87, 860 863.
  • 26
    Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P., Lämmle, B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 3097 3103.
  • 27
    Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M., Lämmle, B. (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. New England Journal of Medicine, 339, 1578 1584.
  • 28
    Furlan, M., Robles, R., Morselli, B., Sandoz, P., Lammie, B. (1999) Recovery and half-life of von Willebrand Factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thrombosis and Haemostasis, 81, 8 13.
  • 29
    Gaddis, T.G., Guthrie, T.H.J., Drew, M.J., Sahud, M., Howe, R.B., Mittelman, A. (1997) Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. American Journal of Hematology, 55, 55 58.
  • 30
    Galbusera, M., Noris, M., Rossi, C., Orisio, S., Caprioli, J., Ruggeri, Z.M., Amadei, B., Ruggenenti, P., Vasile, B., Casari, G., Remuzzi, G. (1999) Increased fragmentation of von Willebrand Factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. Blood, 94, 610 620.
  • 31
    Gerhard, G.S., Hoffman, S.M., Williams, E.C. (1998) Coagulation parameters of ABO group-specific cryosupernatant. American Journal of Clinical Pathology, 109, 379 386.
  • 32
    Gilcher, R.O., Strauss, R.G., Ciavarella, D., Kasprisin, D.O., Kprov, D.D., Klein, H.G., Mcleod, B.C. (1993) Management of renal disorders. Journal of Clinical Apheresis, 8, 258 269.
  • 33
    Gordon, L.I. & Kwaan, H.C. (1999) Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Seminars in Thrombosis and Hemostasis, 25, 217 221.
  • 34
    Gordon, L.I., Kwaan, H.C., Rossi, E.C. (1987) Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Seminars in Hematology, 24, 194 201.
  • 35
    Harkness, D.R., Byrnes, J.J., Lian, E.C., Williams, W.D., Hensley, G.T. (1981) Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. Journal of the American Medical Association, 246, 1931 1933.
  • 36
    Huang, M.M., Bolden, J.B., Barnwell, J.W., Shattil, S.J., Brugge, J.S. (1991) Membrane Glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proceedings of the National Academy of Science of the United States of America, 88, 7844.
  • 37
    Ishii, Y., Ebata, H., Satoh, K., Ueda, H., Harada, M., Mashiko, N., Nouno, R., Tanikawa, K., Hidaka, T. (1984) Case of thrombotic thrombocytopenic purpura. Successful treatment with ticlopidine. Japanese Journal of Clinical Hematology, 25, 1097 1102.
  • 38
    Karmali, M.A., Stelle, B.T., Petric, M., Lim, C. (1983) Sporadic cases of hemolytic–uremic syndrome associated with faecal cytotoxin and cytotoxin-producing E. coli in stools. Lancet, 1, 619 620.
  • 39
    Kovacs, M.J., Roddy, J., Gregoire, S., Cameron, W., Eidus, L., Drouin, J. (1990) TTP following hemorrhagic colitis due to E. coli 0157-H7. American Journal of Medicine, 88, 177 179.
  • 40
    Kwaan, H.C. (1987) Miscellaneous secondary thrombotic microangiopathy. Seminars in Hematology, 24, 141 147.
  • 41
    Leung, D.Y., Moake, J.L., Havens, P.L., Kim, M., Pober, J.S. (1988) Lytic anti-endothelial cell antibodies in haemolytic–uraemic syndrome. Lancet, 2, 183 186.
  • 42
    Lian, E.C.Y., Siddiqui, F.A., Jamieson, G.A., Tandon, N.N. (1991) Platelet agglutinating protein p37 causes platelet activation through its binding to membrane glycoprotein IV. Thrombosis and Haemostasis, 65, 102 106.
  • 43
    Mannucci, P.M., Lombardi, R., Lattuada, A., Ruggenenti, P., Vigano, G.L., Barbui, T., Remuzzi, G. (1989) Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the HUS. Blood, 74, 978 983.
  • 44
    Mazzel, C., Pepkowitz, S., Klapper, E., Goldfinger, D. (1998) Treatment of thrombotic thrombocytopenic purpura: a role for early vincristine administration. Journal of Clinical Apheresis, 13, 20 22.
  • 45
    Moake, J., Chintagumpala, M., Turner, N., McPherson, P., Nolasco, L., Steuber, C., Santiago-Borrero, P., Horowitz, M., Pehta, J. (1994) Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of TTP. Blood, 84, 490 497.
  • 46
    Moake, J.L., Rudy, C.K., Troll, J.H., Weinstein, M.J., Colannino, N.M., Azocar, J., Seder, R.H., Hong, S.L., Deykin, D. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New England Journal of Medicine, 307, 1432 1435.
  • 47
    Moore, J.C., Murphy, W.G., Kelton, J.G. (1990) Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. British Journal of Haematology, 74, 457 464.
  • 48
    Morrison, J. & McMillan, R. (1977) Elevated platelet-associated IgG in thrombotic thrombocytopenic purpura. Journal of the American Medical Association, 238, 1944 1945.
  • 49
    Moschkowitz, E. (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proceedings of the New York Pathological Society, 24, 21 24.
  • 50
    Murgo, A.J. (1987) Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Seminars in Hematology, 24, 161 177.
  • 51
    Murphy, W.G., Moore, J.C., Kelton, J.G. (1987) Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood, 70, 1683 1687.
  • 52
    Murphy, W.G., Moore, J.C., Warkentin, T.E., Hayward, E.P., Kelton, J.G. (1992) Thrombotic thrombocytopenic purpura. Blood Coagulation and Fibrinolysis, 3, 655 659.
  • 53
    Musio, F., Bohen, E.M., Yuan, C.M., Welch, P.G. (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Seminars in Arthritis and Rheumatism, 28, 1 19.
  • 54
    Neame, P.B. (1980) Immunologic and other factors in thrombotic thrombocytopenic purpura. Seminars in Thrombosis and Hemastasis, 6, 416 429.
  • 55
    Owens, M.R., Sweeney, J.D., Tahhan, R.H., Fortkolt, P. (1995) Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis, 10, 178 182.
  • 56
    Pasquale, D., Vidhya, R., DaSilva, K., Tsan, M.F., Lansing, L., Chikkappa, G. (1998) Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine. American Journal of Hematology, 57, 57 61.
  • 57
    Porta, C., Caporali, R., Montecucco, C. (1999) Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica, 84, 260 269.
  • 58
    Remuzzi, G., Marchesi, D., Mecca, G., Misiani, R., Livio, M., Gaetano, G., Donati, M.B. (1978) Hemolytic uremic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet, 2, 871 872.
  • 59
    Ridolfi, R.L. & Bell, W.R. (1981) Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine, 60, 413 428.
  • 60
    Rock, G., Tittley, P., Taylor, J.R. (1988) Abnormal platelet von Willebrand factor interaction in patients with TTP. American Journal of Hematology, 27, 179 183.
  • 61
    Rock, G., Shumak, K., Kelton, J., Blanchette, V.S., Buskard, N., Nair, R., Spasoff, R. (1992) Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion, 32, 710 714.
  • 62
    Rock, G., Chauhan, K., Jamieson, G.A., Tandon, N.N. (1994) Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. British Journal of Haematology, 88, 878 880.
  • 63
    Rock, G., Shumak, K.H., Sutton, D.M.C., Buskard, N.A., Nair, R.C. & the Members of the Canadian Apheresis Group. (1996) Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 383 386.
  • 64
    Rock, G., Kelton, J.G., Shumak, K.H., Buskard, N.A., Sutton, D.M., Benny, W.B. (1998) Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group. British Journal of Haematology, 103, 1031 1036.
  • 65
    Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C., Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. New England Journal of Medicine, 325, 393 397.
  • 66
    Schultz, D.R., Arnold, P.I., Jy, W., Valant, P.A., Gruber, J., Ahn, Y.S., Mao, F.W., Mao, W.W., Horstman, L.L. (1998) Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85-kD form of CD36 as a target antigen. British Journal of Haematology, 103, 849 857.
  • 67
    Shumak, K.H., Rock, G.A., Nair, R.C. (1995) Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Annals of Internal Medicine, 122, 569 572.
  • 68
    Siddiqui, F.A. & Lian, E.C. (1988) Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G. Thrombosis and Haemostasis, 71, 299 304.
  • 69
    Snyder, H.W., Mittelman, A., Oral, A., Messerschmitt, G., Henry, D.H., Korel, S., Betram, J., Guthrie, T.H., Ciarerella, D., Wuest, D., Perkins, W., Baliant, J.R., Cochran, S., Peugueot, R., Jones, F. (1993) Treatment of cancer chemotherapy associated thrombotic thrombocytopenia purpura/hemolytic uremic syndrome by protein A immunoabsorption of plasma. Cancer, 71, 1882 1892.
  • 70
    Sverlick, R.A., Lee, K.H., Wick, T.M., Lawley, T.J. (1992) Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. Journal of Immunology, 148, 78 83.
  • 71
    Tandon, N.N., Rock, G., Jamieson, G.A. (1994) Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. British Journal of Haematology, 88, 816 825.
  • 72
    Tarantolo, S.R., Landmark, J.D., Iwen, P.C., Kessinger, A., Chan, W.C., Hinrichs, S.H. (1997) Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura (Letter). Lancet, 350, 1602.
  • 73
    Torok, T.J., Holman, R.C., Chorba, T.L. (1995) Increasing mortality from thrombotic thrombocytopenic purpura in the United States – analysis of national mortality data, 1968–91. American Journal of Hematology, 50, 84 90.
  • 74
    Tsai, H.-M. & Lian, E.C.Y. (1998) Antibodies to Von Willebrand Factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 1585 1594.
  • 75
    Tsai, H.M., Nagel, R.L., Hatcher, V.B., Sussman, I.I. (1989) Multimers composition of endothelial cell-derived von Willebrand factor. Blood, 73, 2074 2076.
  • 76
    Ucar, A., Fernandez, H.F., Byrnes, J.J., Lian, E.C.Y., Harrington, W.J. (1994) Thrombotic microangiopathy and retroviral infections: a 13-year experience. American Journal of Hematology, 45, 304 309.
  • 77
    Winslow, G.A. & Nelson, E.W. (1995) Thrombotic thrombocytopenic purpura: indications for and results of splenectomy. American Journal of Surgery, 170, 558 561.